BACKGROUND: Current evidence supporting the effectiveness of influenza vaccine in preventing hospitalizations in older adults is insufficient. METHODS: During 3 influenza seasons, 2006-2009, community-dwelling adults aged ≥50 y hospitalized with respiratory symptoms were prospectively enrolled in this study. We tested nose and throat samples for influenza virus by reverse transcriptase-polymerase chain reaction. We estimated vaccine effectiveness by comparing vaccination status between influenza-positive cases and influenza-negative controls using logistic regression models with propensity score adjustment. RESULTS: Overall, 450 (59%) of 763 eligible patients were enrolled; 417 (93%) of enrolled patients had adequate respiratory samples, had known influenza vaccination status, and were community-dwelling. The proportions of influenza-positive patients were 8%, 20%, and 6% in the 3 successive seasons. Of 39 influenza-positive participants, 14 (36%) were vaccinated compared with 250 (66%) of 378 influenza-negative controls. Propensity score-adjusted vaccine effectiveness for the 3 seasons combined was 61.2% (95% confidence interval, 17.5%-81.8%). CONCLUSION: Overall, in this moderately well-vaccinated population of older adults, laboratory-confirmed influenza virus accounted for 9.3% (95% confidence interval, 6.6%-12.1%) of all respiratory hospitalizations during 3 influenza seasons, and influenza vaccination prevented 61.2% of such hospitalizations.
BACKGROUND: Current evidence supporting the effectiveness of influenza vaccine in preventing hospitalizations in older adults is insufficient. METHODS: During 3 influenza seasons, 2006-2009, community-dwelling adults aged ≥50 y hospitalized with respiratory symptoms were prospectively enrolled in this study. We tested nose and throat samples for influenza virus by reverse transcriptase-polymerase chain reaction. We estimated vaccine effectiveness by comparing vaccination status between influenza-positive cases and influenza-negative controls using logistic regression models with propensity score adjustment. RESULTS: Overall, 450 (59%) of 763 eligible patients were enrolled; 417 (93%) of enrolled patients had adequate respiratory samples, had known influenza vaccination status, and were community-dwelling. The proportions of influenza-positive patients were 8%, 20%, and 6% in the 3 successive seasons. Of 39 influenza-positive participants, 14 (36%) were vaccinated compared with 250 (66%) of 378 influenza-negative controls. Propensity score-adjusted vaccine effectiveness for the 3 seasons combined was 61.2% (95% confidence interval, 17.5%-81.8%). CONCLUSION: Overall, in this moderately well-vaccinated population of older adults, laboratory-confirmed influenza virus accounted for 9.3% (95% confidence interval, 6.6%-12.1%) of all respiratory hospitalizations during 3 influenza seasons, and influenza vaccination prevented 61.2% of such hospitalizations.
Authors: W A Orenstein; R H Bernier; T J Dondero; A R Hinman; J S Marks; K J Bart; B Sirotkin Journal: Bull World Health Organ Date: 1985 Impact factor: 9.408
Authors: Tom Jefferson; Carlo Di Pietrantonj; Lubna A Al-Ansary; Eliana Ferroni; Sarah Thorning; Roger E Thomas Journal: Cochrane Database Syst Rev Date: 2010-02-17
Authors: Sharon K Greene; Ping Shi; M Maya Dutta-Linn; Jo Ann Shoup; Virginia L Hinrichsen; Paula Ray; James D Nordin; Leslie Kuckler; Eric S Weintraub; W Katherine Yih Journal: Am J Prev Med Date: 2009-12 Impact factor: 5.043
Authors: William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda Journal: JAMA Date: 2004-09-15 Impact factor: 56.272
Authors: Caitlin Lees; Judith Godin; Janet E McElhaney; Shelly A McNeil; Mark Loeb; Todd F Hatchette; Jason LeBlanc; William Bowie; Guy Boivin; Allison McGeer; André Poirier; Jeff Powis; Makeda Semret; Duncan Webster; Melissa K Andrew Journal: J Infect Dis Date: 2020-07-06 Impact factor: 5.226
Authors: Carlos G Grijalva; Yuwei Zhu; Derek J Williams; Wesley H Self; Krow Ampofo; Andrew T Pavia; Chris R Stockmann; Jonathan McCullers; Sandra R Arnold; Richard G Wunderink; Evan J Anderson; Stephen Lindstrom; Alicia M Fry; Ivo M Foppa; Lyn Finelli; Anna M Bramley; Seema Jain; Marie R Griffin; Kathryn M Edwards Journal: JAMA Date: 2015-10-13 Impact factor: 56.272
Authors: E Kathryn Miller; Jodell Linder; David Kraft; Monika Johnson; Pengcheng Lu; Benjamin R Saville; John V Williams; Marie R Griffin; H Keipp Talbot Journal: J Allergy Clin Immunol Date: 2015-08-06 Impact factor: 10.793
Authors: Ramin Sedaghat Herati; Morgan A Reuter; Douglas V Dolfi; Kathleen D Mansfield; Htin Aung; Osama Z Badwan; Raj K Kurupati; Senthil Kannan; Hildegund Ertl; Kenneth E Schmader; Michael R Betts; David H Canaday; E John Wherry Journal: J Immunol Date: 2014-08-29 Impact factor: 5.422